课题基金 / 基金详情

Predicting the diagnosis of inflammatory and autoimmune arthritis using a data driven approach.

Predicting the diagnosis of inflammatory and autoimmune arthritis using a data driven approach.
使用数据驱动的方法预测炎症和自身免疫性关节炎的诊断。
批准号:
MR/S004084/1
负责人:
Jonathan Kennedy
金额:
$36.26万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Inflammatory arthritis is easy to diagnose once the characteristic changes in the joints is present, for example fusion of the sacroiliac joints for those with ankylosing spondylitis. However, the characteristic changes are normally present after damage has been done, the person has already experienced a great deal of pain and damage and the window of opportunity to stop the disease in the early stages has been lost. An early diagnosis means that disease modifying drugs can be used to slow the progression and possibly greatly change the course of the disease or switch it off. This is especially important as the loss of function occurs in the first 10 years of disease onset and loss of function is the main factor leading to high costs of disease in terms of loss of work and need for assistance and a carer. However, in the early stages many symptoms of inflammatory arthritis are common to aging, injury or wear and tear, for example fatigue, joint pain, swelling. This means they can easily be dismissed by the patient and the doctor and simply treated with pain killers and anti-inflammatory and long delays can occur when symptoms do not resolve. Thus, there is a need to identify predictors that can be used by a GP to rapidly direct and refer patients to specialist treatment. However, considering the waiting lists to see a specialist, it is also important that the predictors have a high positive predictive value so that extra burden is not placed on the hospital system causing greater delays in diagnosis of early disease. New investments in bringing together routinely collected data and new developments in pattern detection methods using large complex datasets means that it is now possible to take advantage of a data driven method approach to tackle this problem. Until now the approach has been taking clinical knowledge from secondary care physicians and applying this knowledge to what they think should be present in primary care records. This study aims to take a data driven approach and to examine early predictors of very early autoimmune inflammatory arthritis. It is possible that the early predictors are all common symptoms such as an infection, antibiotic use, multiple prescriptions for anti-inflammatory drugs and pain killers, time off work as recommended by GP, fatigue and fever. However, the pattern of these common symptoms and timing of when they occur relative to each other, may be the main predictive factor.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1093/rap/rkab042
发表时间: 2021
期刊: Rheumatology advances in practice
影响因子: 3.1
作者: [Cooksey R, Rahman MA, Kennedy J, Brophy S, Choy E]
通讯作者: Choy E
DOI: 10.1371/journal.pone.0237676
发表时间: 2020
期刊: PloS one
影响因子: 3.7
作者: [Cooksey R, Kennedy J, Dennis MS, Escott-Price V, Lyons RA, Seaborne M, Brophy S]
通讯作者: Brophy S
DOI: 10.1089/cap.2017.0003
发表时间: 2018-04
期刊: Journal of child and adolescent psychopharmacology
影响因子: 1.9
作者: [Brophy S, Kennedy J, Fernandez-Gutierrez F, John A, Potter R, Linehan C, Kerr M]
通讯作者: Kerr M
DOI: 10.1016/j.eclinm.2023.102077
发表时间: 2023-07
期刊: ECLINICALMEDICINE
影响因子: 15.1
作者: [Costello, Ruth E., Tazare, John, Piehlmaier, Dominik, Herrett, Emily, Parker, Edward P. K., Zheng, Bang, Mans, Kathryn E., Henderson, Alasdair D., Carreira, Helena, Bidulka, Patrick, Wong, Angel Y. S., Warren-Gash, Charlotte, Hayes, Joseph F., Quint, Jennifer K., MacKenna, Brian, Mehrkar, Amir, Eggo, Rosalind M., Katikireddi, Srinivasa Vittal, Tomlinson, Laurie, Langan, Sinead M., Mathur, Rohini]
通讯作者: Mathur, Rohini
7
    国内基金
    海外基金
    均相液相生物芯片检测系统的构建及其在癌症早期诊断上的应用
    • 批准号:
      82372089
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      李万万
    • 依托单位:
    环境抗雄激素干预AR/TGFB1I1致尿道下裂血管内皮细胞发育异常的机制及其“预警信号”在早期诊断中的价值
    • 批准号:
      82371605
    • 项目类别:
      面上项目
    • 资助金额:
      46.00万元
    • 批准年份:
      2023
    • 负责人:
      蒋君涛
    • 依托单位:
    基于密度泛函理论金原子簇放射性药物设计、制备及其在肺癌诊疗中的应用研究
    • 批准号:
      82371997
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      张春富
    • 依托单位:
    基于质谱贴片的病原菌标志物检测及伤口感染诊断应用
    • 批准号:
      82372148
    • 项目类别:
      面上项目
    • 资助金额:
      60.00万元
    • 批准年份:
      2023
    • 负责人:
      黄琳
    • 依托单位: